US Stock MarketDetailed Quotes

LYRA Lyra Therapeutics

Watchlist

0.189
+0.007+3.90%

Close Nov 22 16:00 ET

0.186
-0.003-1.48%

Post 19:43 ET

12.37MMarket Cap-126P/E (TTM)

Lyra Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

-64.15%195K

30.57%598K

29.76%532K

14.31%1.56M

1,227.27%146K

51.53%544K

-12.76%458K

-12.39%410K

378.25%1.36M

-95.94%11K

Operating revenue

-64.15%195K

30.57%598K

29.76%532K

14.31%1.56M

1,227.27%146K

51.53%544K

-12.76%458K

-12.39%410K

378.25%1.36M

-95.94%11K

Cost of revenue

Gross profit

Operating expense

-43.39%9.83M

19.74%18.4M

35.73%24.06M

19.05%67.09M

20.02%16.62M

14.40%17.37M

2.97%15.37M

43.01%17.72M

28.37%56.35M

-0.42%13.85M

Selling and administrative expenses

-21.43%3.93M

12.45%5.14M

13.48%5.82M

8.55%19.06M

-0.95%4.36M

-2.61%5M

10.60%4.57M

31.87%5.13M

23.58%17.56M

23.32%4.4M

-General and administrative expense

-21.43%3.93M

12.45%5.14M

13.48%5.82M

8.55%19.06M

-0.95%4.36M

-2.61%5M

10.60%4.57M

31.87%5.13M

23.58%17.56M

23.32%4.4M

Research and development costs

-52.28%5.9M

22.83%13.26M

44.79%18.24M

23.80%48.03M

29.79%12.27M

23.09%12.37M

0.06%10.8M

48.10%12.6M

30.66%38.8M

-8.62%9.45M

Operating profit

42.72%-9.64M

-19.41%-17.81M

-35.87%-23.52M

-19.16%-65.53M

-19.06%-16.48M

-13.50%-16.83M

-3.55%-14.91M

-45.18%-17.31M

-26.08%-54.99M

-1.47%-13.84M

Net non-operating interest income expense

-51.68%576K

-4.68%855K

1.31%1.09M

332.18%4.5M

43.41%1.34M

1,886.67%1.19M

2,538.24%897K

7,557.14%1.07M

920.59%1.04M

4,342.86%933K

Non-operating interest income

-51.68%576K

-4.68%855K

1.31%1.09M

332.18%4.5M

43.41%1.34M

1,886.67%1.19M

2,538.24%897K

7,557.14%1.07M

920.59%1.04M

4,342.86%933K

Other net income (expense)

-2.8M

-1,857.85%-31.17M

-20.97%-1.59M

-1.59M

-1.32M

Special income (charges)

---2.8M

-1,857.85%-31.17M

----

-20.97%-1.59M

--0

---1.59M

----

---1.32M

-Less：Restructuring and merger&acquisition

--2.8M

--6.45M

----

--0

----

-Less:Impairment of capital assets

--0

1,452.70%24.72M

----

20.97%1.59M

--0

--1.59M

----

--1.32M

Income before tax

24.11%-11.87M

-208.34%-48.12M

-38.16%-22.44M

-13.31%-62.62M

-6.45%-15.14M

-5.89%-15.64M

-8.63%-15.61M

-36.35%-16.24M

-27.01%-55.27M

-4.44%-14.22M

Income tax

-56.25%7K

0.00%12K

0.00%14K

353.85%59K

30.77%17K

16K

12K

14K

13K

Net income

24.14%-11.87M

-208.18%-48.13M

-38.12%-22.45M

-13.39%-62.68M

-6.47%-15.16M

-5.99%-15.65M

-8.72%-15.62M

-36.47%-16.26M

-27.04%-55.28M

-4.54%-14.24M

Net income continuous Operations

24.14%-11.87M

-208.18%-48.13M

-38.12%-22.45M

-13.39%-62.68M

-6.47%-15.16M

-5.99%-15.65M

-8.72%-15.62M

-36.47%-16.26M

-27.04%-55.28M

-4.54%-14.24M

Minority interest income

Net income attributable to the parent company

24.14%-11.87M

-208.18%-48.13M

-38.12%-22.45M

-13.39%-62.68M

-6.47%-15.16M

-5.99%-15.65M

-8.72%-15.62M

-36.47%-16.26M

-27.04%-55.28M

-4.54%-14.24M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

24.14%-11.87M

-208.18%-48.13M

-38.12%-22.45M

-13.39%-62.68M

-6.47%-15.16M

-5.99%-15.65M

-8.72%-15.62M

-36.47%-16.26M

-27.04%-55.28M

-4.54%-14.24M

Basic earnings per share

33.33%-0.18

-105.56%-0.74

20.45%-0.35

31.15%-1.26

38.89%-0.22

32.50%-0.27

14.29%-0.36

52.17%-0.44

45.37%-1.83

65.71%-0.36

Diluted earnings per share

33.33%-0.18

-105.56%-0.74

20.45%-0.35

31.15%-1.26

38.89%-0.22

32.50%-0.27

14.29%-0.36

52.17%-0.44

45.37%-1.83

65.71%-0.36

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	-64.15%195K	30.57%598K	29.76%532K	14.31%1.56M	1,227.27%146K	51.53%544K	-12.76%458K	-12.39%410K	378.25%1.36M	-95.94%11K
Operating revenue	-64.15%195K	30.57%598K	29.76%532K	14.31%1.56M	1,227.27%146K	51.53%544K	-12.76%458K	-12.39%410K	378.25%1.36M	-95.94%11K
Cost of revenue
Gross profit
Operating expense	-43.39%9.83M	19.74%18.4M	35.73%24.06M	19.05%67.09M	20.02%16.62M	14.40%17.37M	2.97%15.37M	43.01%17.72M	28.37%56.35M	-0.42%13.85M
Selling and administrative expenses	-21.43%3.93M	12.45%5.14M	13.48%5.82M	8.55%19.06M	-0.95%4.36M	-2.61%5M	10.60%4.57M	31.87%5.13M	23.58%17.56M	23.32%4.4M
-General and administrative expense	-21.43%3.93M	12.45%5.14M	13.48%5.82M	8.55%19.06M	-0.95%4.36M	-2.61%5M	10.60%4.57M	31.87%5.13M	23.58%17.56M	23.32%4.4M
Research and development costs	-52.28%5.9M	22.83%13.26M	44.79%18.24M	23.80%48.03M	29.79%12.27M	23.09%12.37M	0.06%10.8M	48.10%12.6M	30.66%38.8M	-8.62%9.45M
Operating profit	42.72%-9.64M	-19.41%-17.81M	-35.87%-23.52M	-19.16%-65.53M	-19.06%-16.48M	-13.50%-16.83M	-3.55%-14.91M	-45.18%-17.31M	-26.08%-54.99M	-1.47%-13.84M
Net non-operating interest income expense	-51.68%576K	-4.68%855K	1.31%1.09M	332.18%4.5M	43.41%1.34M	1,886.67%1.19M	2,538.24%897K	7,557.14%1.07M	920.59%1.04M	4,342.86%933K
Non-operating interest income	-51.68%576K	-4.68%855K	1.31%1.09M	332.18%4.5M	43.41%1.34M	1,886.67%1.19M	2,538.24%897K	7,557.14%1.07M	920.59%1.04M	4,342.86%933K
Other net income (expense)	-2.8M	-1,857.85%-31.17M		-20.97%-1.59M	0		-1.59M		-1.32M
Special income (charges)	---2.8M	-1,857.85%-31.17M	----	-20.97%-1.59M	--0	--0	---1.59M	----	---1.32M	---1.32M
-Less：Restructuring and merger&acquisition	--2.8M	--6.45M	----	----	----	--0	--0	----	----	----
-Less:Impairment of capital assets	--0	1,452.70%24.72M	----	20.97%1.59M	--0	--0	--1.59M	----	--1.32M	--1.32M
Income before tax	24.11%-11.87M	-208.34%-48.12M	-38.16%-22.44M	-13.31%-62.62M	-6.45%-15.14M	-5.89%-15.64M	-8.63%-15.61M	-36.35%-16.24M	-27.01%-55.27M	-4.44%-14.22M
Income tax	-56.25%7K	0.00%12K	0.00%14K	353.85%59K	30.77%17K	16K	12K	14K	13K	13K
Net income	24.14%-11.87M	-208.18%-48.13M	-38.12%-22.45M	-13.39%-62.68M	-6.47%-15.16M	-5.99%-15.65M	-8.72%-15.62M	-36.47%-16.26M	-27.04%-55.28M	-4.54%-14.24M
Net income continuous Operations	24.14%-11.87M	-208.18%-48.13M	-38.12%-22.45M	-13.39%-62.68M	-6.47%-15.16M	-5.99%-15.65M	-8.72%-15.62M	-36.47%-16.26M	-27.04%-55.28M	-4.54%-14.24M
Minority interest income
Net income attributable to the parent company	24.14%-11.87M	-208.18%-48.13M	-38.12%-22.45M	-13.39%-62.68M	-6.47%-15.16M	-5.99%-15.65M	-8.72%-15.62M	-36.47%-16.26M	-27.04%-55.28M	-4.54%-14.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	24.14%-11.87M	-208.18%-48.13M	-38.12%-22.45M	-13.39%-62.68M	-6.47%-15.16M	-5.99%-15.65M	-8.72%-15.62M	-36.47%-16.26M	-27.04%-55.28M	-4.54%-14.24M
Basic earnings per share	33.33%-0.18	-105.56%-0.74	20.45%-0.35	31.15%-1.26	38.89%-0.22	32.50%-0.27	14.29%-0.36	52.17%-0.44	45.37%-1.83	65.71%-0.36
Diluted earnings per share	33.33%-0.18	-105.56%-0.74	20.45%-0.35	31.15%-1.26	38.89%-0.22	32.50%-0.27	14.29%-0.36	52.17%-0.44	45.37%-1.83	65.71%-0.36
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data